Difference between revisions of "Cancer Types"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 665: | Line 665: | ||
: [[Oncocytic carcinoma]] | : [[Oncocytic carcinoma]] | ||
: [[Sebaceous carcinoma]] | : [[Sebaceous carcinoma]] | ||
| − | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
| − | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
: [[Acinic cell carcinoma]] | : [[Acinic cell carcinoma]] | ||
</div> | </div> | ||
| Line 676: | Line 676: | ||
'''Intraductal proliferative lesions''' | '''Intraductal proliferative lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : | + | : Usual ductal hyperplasia |
| − | : | + | : Columnar cell lesions |
| − | : | + | : Atypical ductal hyperplasia |
: [[Ductal carcinoma in situ]] | : [[Ductal carcinoma in situ]] | ||
</div> | </div> | ||
| Line 698: | Line 698: | ||
'''Benign epithelial proliferations''' | '''Benign epithelial proliferations''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
| − | : [[Microglandular adenosis]],[[atypical microglandular adenosis | + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] |
: [[Radial scar and complex sclerosing lesion]] | : [[Radial scar and complex sclerosing lesion]] | ||
: [[Tubular adenoma]] | : [[Tubular adenoma]] | ||
| − | : | + | : Lactating adenoma |
| − | : | + | : Apocrine adenoma |
| − | : | + | : Ductal adenoma |
| − | : | + | : Pleomorphic adenoma |
</div> | </div> | ||
</div> | </div> | ||
| Line 712: | Line 712: | ||
'''Myoepithelial and epithelial–myoepithelial lesions''' | '''Myoepithelial and epithelial–myoepithelial lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
| − | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 722: | Line 722: | ||
: Nodular fasciitis | : Nodular fasciitis | ||
: Benign vascular lesions | : Benign vascular lesions | ||
| − | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
| − | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
| − | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
: Inflammatory myofibroblastic tumour | : Inflammatory myofibroblastic tumour | ||
: Lipoma | : Lipoma | ||
: Granular cell tumour and benign peripheral | : Granular cell tumour and benign peripheral | ||
: nerve-sheath tumour | : nerve-sheath tumour | ||
| − | : Angiosarcoma | + | : [[Angiosarcoma]] |
: Liposarcoma | : Liposarcoma | ||
: Rhabdomyosarcoma | : Rhabdomyosarcoma | ||
| Line 742: | Line 742: | ||
: [[Fibroadenoma]] | : [[Fibroadenoma]] | ||
: [[Phyllodes tumour]] | : [[Phyllodes tumour]] | ||
| − | : | + | : Hamartoma |
</div> | </div> | ||
</div> | </div> | ||
| Line 749: | Line 749: | ||
'''Tumors of the nipple''' | '''Tumors of the nipple''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : | + | : Nipple adenoma |
: Syringomatous tumour | : Syringomatous tumour | ||
: [[Paget disease]] | : [[Paget disease]] | ||
| Line 771: | Line 771: | ||
'''Tumors of the male breast''' | '''Tumors of the male breast''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Gynaecomastia | + | : [[Gynaecomastia]] |
: [[Carcinoma of the male breast]] | : [[Carcinoma of the male breast]] | ||
</div> | </div> | ||
| Line 780: | Line 780: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Inherited syndromes associated with an increased risk of breast cancer: Introduction | : Inherited syndromes associated with an increased risk of breast cancer: Introduction | ||
| − | : BRCA1 and BRCA2 | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
| − | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
: Ataxia telangiectasia syndrome | : Ataxia telangiectasia syndrome | ||
: Cowden syndrome | : Cowden syndrome | ||
Revision as of 16:12, 23 August 2017
These classifications are based on WHO/IARC guidelines. See [1] for further details.
Common Adult Cancers
Common Pediatric Cancers
WHO Classification of Tumours of the Central Nervous System (2016)
Expand
CNS Tumors
WHO Classification of Pathology and Genetics of Head and Neck Tumors
Expand
Head and Neck Tumors
WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)
WHO Classification of Tumors of Endocrine Organs
Expand
Endocrine Tumors
WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (2015)
WHO Classification of Tumors of Female Reproductive Organs (2014)
WHO Classification of Tumors of Soft Tissue and Bone (2013)
WHO Classification of Tumors of the Breast (2012)
Expand
Breast Tumors
WHO Classification of Tumours of the Digestive System (2010)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008)
Expand
Hematological and Lymphoid Neoplasms
Miscellaneous Cancer Types
Expand
Miscellaneous Tumors